Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Scientific Sessions
An announcement on partners to collaborate in the TRANSFORM trial was made today during the American Heart Association’s (AHA) 2023 Scientific Sessions. Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.